These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 33275687)
1. How well do platelets prevent bleeding? Triulzi DJ Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):518-522. PubMed ID: 33275687 [TBL] [Abstract][Full Text] [Related]
2. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695 [TBL] [Abstract][Full Text] [Related]
3. Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study. Tay J; Allan D; Beattie S; Bredeson C; Fergusson D; Maze D; Sabloff M; Thavorn K; Tinmouth A BMJ Open; 2016 Oct; 6(10):e013483. PubMed ID: 27798034 [TBL] [Abstract][Full Text] [Related]
4. New strategies for the optimal use of platelet transfusions. Blajchman MA; Slichter SJ; Heddle NM; Murphy MF Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082 [TBL] [Abstract][Full Text] [Related]
6. Triggers for prophylactic use of platelet transfusions and optimal platelet dosing in thrombocytopenic dogs and cats. Abrams-Ogg AC Vet Clin North Am Small Anim Pract; 2003 Nov; 33(6):1401-18. PubMed ID: 14664205 [TBL] [Abstract][Full Text] [Related]
7. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia. Vinholt PJ; Alnor A; Nybo M; Hvas AM Platelets; 2016 Sep; 27(6):547-54. PubMed ID: 27025360 [TBL] [Abstract][Full Text] [Related]
8. A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger. Zumberg MS; del Rosario ML; Nejame CF; Pollock BH; Garzarella L; Kao KJ; Lottenberg R; Wingard JR Biol Blood Marrow Transplant; 2002; 8(10):569-76. PubMed ID: 12434952 [TBL] [Abstract][Full Text] [Related]
9. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323 [TBL] [Abstract][Full Text] [Related]
10. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Wandt H; Frank M; Ehninger G; Schneider C; Brack N; Daoud A; Fackler-Schwalbe I; Fischer J; Gäckle R; Geer T; Harms P; Löffler B; Ohl S; Otremba B; Raab M; Schönrock-Nabulsi P; Strobel G; Winter R; Link H Blood; 1998 May; 91(10):3601-6. PubMed ID: 9572994 [TBL] [Abstract][Full Text] [Related]
11. Pathogen-reduced platelets for the prevention of bleeding. Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569 [TBL] [Abstract][Full Text] [Related]
12. Neonatal Platelet Transfusions and Future Areas of Research. Sola-Visner M; Bercovitz RS Transfus Med Rev; 2016 Oct; 30(4):183-8. PubMed ID: 27282660 [TBL] [Abstract][Full Text] [Related]
13. New thoughts on the correct dosing of prophylactic platelet transfusions to prevent bleeding. Slichter SJ Curr Opin Hematol; 2011 Nov; 18(6):427-35. PubMed ID: 21946073 [TBL] [Abstract][Full Text] [Related]
14. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342 [TBL] [Abstract][Full Text] [Related]
15. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838 [TBL] [Abstract][Full Text] [Related]
16. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients. Drews RE Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693 [TBL] [Abstract][Full Text] [Related]